Abstract
To assess the prevalence ofHelicobacter pylori in diabetes mellitus, a serological test was used to detect antibodies toH. pylori in patients with diabetes mellitus. Within six months, 45 insulin-dependent, 98 non-insulin-dependent, and a control group of 159 outpatients were enrolled in this study. The age adjusted seroprevalence rates ofHelicobacter pylori were determined using a commercial anti-Helicobacter pylori IgG and IgA ELISA (Bio-Rad). The prevalence rates increased with age in all age groups until 60–70 years. In diabetic patients, the frequency ofHelicobacter pylori infection was higher than in control subjects in nearly all age groups, reaching significance in three age categories for NIDDM patients and in one age category in IDDM patients. This higher seroprevalence could not be explained by differences in socioeconomic status or use of antibiotics.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Dixon MF:Campylobacter pylori and chronic gastritis.In Campylobacter pylori and Gastroduodenal Disease. BJ Rathbone, RV Heatley (eds). Oxford, Blackwell Scientific Publications, 1989, pp 106–116
Tytgat GNJ, Axon ATR, Dixon MF, Graham DY, Lee A, Marchall BJ:Helicobacter pylori: Causal agent in peptic ulcer disease? Working party report of the world congress of gastroenterology, 1990, pp 36–45
Feng Y, Wang Y:Campylobacter pylori in patients with gastritis, peptic ulcer and carcinoma of the stomach in Lanzhou, China. Lancet 1:1055–1056, 1988
Feldman M, Schiller LR: Disorders of gastrointestinal motility associated with diabetes mellitus. Ann Intern Med 98:378–384, 1983
Katz LA, Spiro HM: Gastrointestinal manifestations of diabetes. N Engl J Med 275:1350–1361, 1966
Scarpello JHB, Sladen GE: Progress report: Diabetes and the gut. Gut 19:1153–1162, 1978
Feldman M, Corbett DB, Ramsey EJ, Walsh JH, Richardson CT: Abnormal gastric function in longstanding, insulin-dependent diabetic patients. Gastroenterology 77:12–17, 1979
Crabtree JE, Shallcross TM, Heatley RV, Wyatt JI: Evaluation of a commercial ELISA for serodiagnosis ofHelicobacter pylori infection. J Clin Pathol 44:326–328, 1991
Graham DY, Malaty HM, Evans DG, Evans DJ Jr, Klein PD, Adam E: Epidemiology ofHelicobacter pylori in an asymptomatic population in the United States: Effect of age, race and socioeconomic status. Gastroenterology 100:1495–1501, 1991
Sitas F, Forman D, Yarnell JWG, Burr ML, Elwood PC, Pedley S, Marks KJ:Helicobacter pylori infection rates in relation to age and social class in a population of Welsh men. Gut 32:25–28, 1991
Drumm B, Perez-Perez GI, Blaser MJ, Sherman PM: Intrafamilial clustering ofHelicobacter pylori infection. N Engl J Med 322:359–363, 1990
Graham DY, Adam E, Reddy GT, Agarwal JP, Agarwal R, Evans DJ, Malaty HM, Evans DG: Seroepidemiology ofHelicobacter pylori infection in India. Comparison of developing and developed countries. Dig Dis Sci 36:1084–1088, 1991
Diepersloot RJA, Bouter KP, Beyer WEP, Hoekstra JBL, Masurel N: Humoral immune response and delayed type hypersensitivity to influenza vaccine in patients with diabetes mellitus. Diabetologia 30:397–401, 1987
Glass EJ, Stewart J, Matthews DM, Collier A, Clarke BF, Weir DM: Impairment of monocyte “lectin-like” receptor activity in type 1 (insulin dependent) diabetic patients. Diabetologia 30:228–231, 1987
Ohno Y, Aoki N, Nishimura A: In vitro production of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 77:1072–1077, 1993
Hussein MJ, Alviggi L, Millwand BA, Leslie RDG, Pyke DA, Vergani D: Evidence that the reduced number of natural killer cells in type 1 (insulin dependent) may be genetically determinated. Diabetologia 30:907–911, 1987
Nolan CM, Beaty HN, Bagdade JD: Further characterization of the impaired bactericidal function of granulocytes in patients with poorly controlled diabetes. Diabetes 27:889–894, 1978
Blaser MJ:Helicobacter pylori: Its role in disease. Clin Infect Dis 15:386–393, 1992
Author information
Authors and Affiliations
Additional information
This work was supported by Glaxo BV, The Netherlands.
Address for reprint requests: University Hospital Utrecht, Department of Gastroenterology, Room F2.618, PO Box 85500, 3508 GA Utrecht, The Netherlands.
Rights and permissions
About this article
Cite this article
Oldenburg, B., Diepersloot, R.J.A. & Hoekstra, J.B.L. High seroprevalence ofHelicobacter pylori in diabetes mellitus patients. Digest Dis Sci 41, 458–461 (1996). https://doi.org/10.1007/BF02282318
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02282318